Skip to main content
. 2020 Mar 9;11(3):330–339. doi: 10.1016/j.jpha.2020.03.005

Fig. 1.

Fig. 1

Schematic illustration showing the cellular uptake of cisplatin-loaded DNA-nanothread (CPT-DNA-NT) towards the tumor cells (HeLa) in vitro; (A) Binding of DNA-NT on the cell surface. (B) Internalization of CPT-DNA-NT by scavenger receptors. (C) Intracellular CPT delivery.